Arm Holdings' Q3 2026 earnings print, filed as a 6-K on April 21, 2026, delivered headline numbers that cleared consensus on both earnings per share and revenue — yet the forensic picture underneath that beat is considerably more complicated. The adjusted EPS of $0.43 surpassed the $0.33 estimate by a meaningful margin, and revenue came in at $1.24 billion against a consensus that implied nearly no upside. What the print simultaneously exposed, however, is a pronounced divergence between the per-share figure reported under non-GAAP convention and the GAAP EPS of $0.75 filed directly with the SEC, alongside a total revenue figure in the SEC filing of $4.007 billion that does not reconcile with the reported quarterly figure — a structural discrepancy that any institutional holder is obligated to parse before drawing narrative conclusions about trajectory.
The Result
On an adjusted basis, ARM reported Q3 EPS of $0.43 against a consensus estimate of $0.33, representing a positive surprise of approximately 30.3%. Revenue of $1.242 billion came in against expectations with a surprise of approximately 0.01% — a near-exact match to consensus on the top line. The SEC-filed GAAP EPS stands at $0.75, reflecting the impact of items not captured in the adjusted figure. The SEC-filed revenue of $4.007 billion represents a period or cumulative figure that requires explicit reconciliation against the quarterly $1.242 billion for investors tracking sequential momentum.
Print Scorecard
| Metric | Actual | Estimate | Surprise % | Source | Date |
| EPS (Adjusted) | $0.43 | $0.33 | +30.3% | Benzinga consensus / 6-K | 2026-04-21 |
|---|---|---|---|---|---|
| EPS (GAAP, SEC) | $0.75 | — | — | SEC 6-K filing | 2026-04-21 |
| Revenue (Quarterly) | $1.242B | ~$1.242B | +0.01% | 6-K / Benzinga consensus | 2026-04-21 |
| Revenue (SEC-filed) | $4.007B | — | — | SEC 6-K filing | 2026-04-21 |
| Gross Margin | 96.98% | — | — | SEC 6-K filing | 2026-04-21 |
| Operating Margin | 20.74% | — | — | SEC 6-K filing | 2026-04-21 |
| Net Margin | 19.77% | — | — | SEC 6-K filing | 2026-04-21 |
Narrative Test
The prevailing narrative entering this print positioned ARM as a structural beneficiary of the AI silicon buildout, with institutional accumulation patterns suggesting positive expectations around the company's ongoing business model transformation — specifically its royalty rate escalation and licensing mix shift toward higher-value compute architectures. That narrative was neither cleanly confirmed nor broken; it was complicated.
On the surface, the adjusted EPS beat of 30.3% reads as confirmation. A company in the middle of a licensing model transformation that exceeds earnings estimates by that magnitude would typically reinforce the bull thesis. But two data points resist that reading. First, the revenue surprise of 0.01% reveals that top-line growth is not accelerating beyond what the market had already modeled — the earnings outperformance was therefore a margin event, not a volume or pricing event, and those are structurally different signals. Second, the post-print market reaction, with shares rising 13.63% on the day to $237.30, brings the stock to a trailing P/E of 279.18 — a multiple that prices in an extraordinary duration of compounding that the current operating margin of 20.74% does not yet support on a GAAP basis.
The forensic rebuttal to the prevailing narrative is precise: the dominant media flow around ARM on the print date was occupied by UK political developments and macro cross-currents — Iran trade talks, Federal Reserve rate trajectory, and employment data. None of this is operationally relevant to ARM's royalty economics. The gap between what is being discussed and what actually drives ARM's intrinsic value has widened, not narrowed, after this print. The noted fair value gap of approximately 74% above fundamentally supported levels is not a function of this quarter's results; those results, while clean on an adjusted basis, did not provide the magnitude of upside required to close that gap.
Forensic Dissection
The gross margin of 96.98% is the most structurally significant line in the filing. For a semiconductor IP licensor, margins at this level are the core economic argument — ARM does not manufacture, it licenses architecture, and a gross margin approaching 97% confirms that the licensing model is functioning with minimal incremental cost of delivery. This is not a new story, but it validates the model's scalability.
The divergence between gross margin (96.98%) and operating margin (20.74%) signals that operating expenditure — predominantly R&D and sales infrastructure — is consuming roughly 76 percentage points of gross profit. For a company in active architectural development across compute, automotive, and AI-adjacent verticals, this spending level is defensible, but it does constrain near-term free cash flow conversion relative to what the gross margin alone implies.
Net margin of 19.77% against an operating margin of 20.74% suggests minimal below-the-line distortion — interest and tax effects are not materially degrading the operating result, which is a clean structural read.
The GAAP EPS of $0.75 exceeding the adjusted EPS of $0.43 is an atypical relationship. Ordinarily, adjusted figures exceed GAAP figures due to stock-based compensation addbacks and restructuring exclusions. A GAAP EPS that runs above the adjusted figure requires explicit management disclosure of what adjustments are running in reverse — this is a specific item that analysts and institutional holders should surface directly from the 6-K footnotes rather than accept at face value in either direction.
Management guidance direction was unchanged per available data, which means the forward earnings curve is still priced on prior-period assumptions rather than an upward revision — a data point that makes the 13.63% single-day price appreciation analytically difficult to reconcile with fundamental revision alone.
Watchlist — Next Quarter and Next 30 Days
- Reconcile the SEC-filed revenue figure of $4.007 billion against the quarterly $1.242 billion; determine whether the larger figure represents a cumulative nine-month period or a restatement, as the answer materially changes the sequential growth read.
- Monitor royalty revenue mix versus licensing revenue for any shift in proportional contribution, which is the primary leading indicator of whether ARM's pricing power narrative is compounding or plateauing.
- Track short interest at 11.46% of float against price behavior; at a trailing P/E of 279.18 and a 52-week return of 103.70%, any deterioration in guidance language or macro demand signals in AI capex would pressure a structurally elevated short base into acute covering or amplified drawdown dynamics.
- Assess whether the GAAP-to-adjusted EPS inversion ($0.75 GAAP versus $0.43 adjusted) is a one-period anomaly or reflects a recurring structural item that alters the comparability of forward consensus estimates built on adjusted figures.
ARM's Q3 print confirms that its licensing model is operating with near-maximal gross efficiency, but the 74% estimated gap between current price and fundamentally supported value means the stock's durability depends entirely on whether AI infrastructure spending produces royalty volume growth at a rate that can eventually compress a 279x trailing earnings multiple — a condition that one quarter of adjusted EPS outperformance, on flat revenue surprise, does not yet establish.